Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Verona Pharma’s $650 Million Financing Round
Conn’s Chapter 11 Bankruptcy Proceedings
Sidley Austin is representing Conn’s Inc. in the deal, and Simpson Thacher & Bartlett is representing JPMorgan Chase Bank, N.A. as Prepetition ABL Agent and DIP...
Amylyx Pharmaceuticals’ Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals
Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...
Kaltroco’s Minority Investment in Dave Cantin Group
Hogan Lovells acted for Dave Cantin Group on the deal. The Dave Cantin Group (DCG), a leading advisor to retail automotive groups and their owners, received...
Acerus Pharmaceuticals’ Reverse Vesting Transaction
Sidley advised Acerus Pharmaceuticals on the restructuring. Acerus Pharmaceuticals recently obtained a novel order from the United States Bankruptcy Court for the District of Delaware recognizing...
Accelerate Diagnostics’ Successful Restructuring
Sidley advised Accelerate Diagnostics on the operation. Accelerate Diagnostics, Inc. completed the out of court restructuring of its $92 million in funded debt. The company closed...
IBM’s Reorganisation For The Separation of Kyndryl
Hogan Lovells, Paul, Weiss and Skrine, Bär & Karrer, Cobalt and Suciu Popa represented International Business Machines Corporation (IBM) on the matter. Vinge advised IBM Sweden....
DP World’s $1.2 Billion Acquisition of Syncreon
White & Case LLP advised DP World on its US$1.2 billion acquisition of syncreon. Hogan Lovells represented syncreon Newco B.V. DP World is a leading provider...